Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China

• Principais autores: Wanyi Xu (Autor), Zhiqi Zhang (Autor), Dandan Li (Autor), Wendi Dai (Autor), Chen Pan (Autor), Mingxing Guo (Autor), Ying Zhao (Autor), Xiangli Cui (Autor)
• Formato: Livro
• Publicado em: BMC, 2023-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background This study aims to evaluate the cost-effectiveness of immunosuppressive therapy for patients with progressive idiopathic membranous nephropathy (IMN) from the Chinese healthcare system perspective. Methods To estimate the cost-effectiveness of four regimens namely cyclophosphamid...